4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-019773
Chief Financial Officer sold 7,500 shares at $235.00 ($1,762,500)
- Chief Financial Officer acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Option exercise | +2,500 | $57.76 | $144,400 | 108,926 | D |
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Option exercise | +2,500 | $57.76 | $144,400 | 111,426 | D |
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Option exercise | +2,500 | $57.76 | $144,400 | 113,926 | D |
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Sale | −7,500 | $235.00 | $1,762,500 | 106,426 | D |
| Derivatives | |||||||
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Option exercise · ResMed Common Stock Options | −2,500 | 7,500 | D | ||
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Option exercise · ResMed Common Stock Options | −2,500 | 5,000 | D | ||
| Sandercock Brett Chief Financial Officer | 2022-07-22 | Option exercise · ResMed Common Stock Options | −2,500 | 2,500 | D | ||
| Open-market sales · 7,500 sh · avg $235.00 · $1,762,500 | |||||||
Loading xslF345X03/form4.xml…